EIKEN CHEMICAL CO.,LTD. Logo

EIKEN CHEMICAL CO.,LTD.

Manufacturer of clinical diagnostics, medical equipment, and gene amplification technology.

4549 | T

Overview

Corporate Details

ISIN(s):
JP3160700005
LEI:
Country:
Japan
Address:
台東区台東四丁目19番9号

Description

EIKEN CHEMICAL CO., LTD. is a manufacturer specializing in clinical diagnostics and medical equipment. Established in 1939, the company has a history of innovation, including being the first in Japan to commercialize powdered culture media for microbiological investigations. Its core business encompasses the development, manufacturing, and sale of a wide range of diagnostic reagents and equipment. Key product areas include Fecal Immunochemical Test (FIT) systems for colorectal cancer screening, immunological and serological reagents, and microbiological diagnostics. EIKEN is also the developer of the proprietary Loop-mediated Isothermal Amplification (LAMP) method, a rapid gene amplification technology widely used in molecular diagnostics for infectious diseases and other applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-10-25 03:45
訂正有価証券報告書-第80期(平成29年4月1日-平成30年3月31日)
Japanese 515.6 KB
2022-08-05 03:01
確認書
Japanese 9.2 KB
2022-08-05 03:00
四半期報告書-第85期第1四半期(令和4年4月1日-令和4年6月30日)
Japanese 168.4 KB
2022-06-22 03:01
内部統制報告書-第84期(令和3年4月1日-令和4年3月31日)
Japanese 25.8 KB
2022-06-22 03:00
有価証券報告書-第84期(令和3年4月1日-令和4年3月31日)
Japanese 1.5 MB
2022-06-22 03:00
確認書
Japanese 9.2 KB
2022-02-10 02:00
四半期報告書-第84期第3四半期(令和3年10月1日-令和3年12月31日)
Japanese 183.7 KB
2021-11-10 02:00
四半期報告書-第84期第2四半期(令和3年7月1日-令和3年9月30日)
Japanese 229.7 KB
2021-08-06 03:00
四半期報告書-第84期第1四半期(令和3年4月1日-令和3年6月30日)
Japanese 149.0 KB
2021-06-23 03:01
内部統制報告書-第83期(令和2年4月1日-令和3年3月31日)
Japanese 24.4 KB
2021-06-23 03:00
確認書
Japanese 8.4 KB
2021-06-23 03:00
有価証券報告書-第83期(令和2年4月1日-令和3年3月31日)
Japanese 998.1 KB
2021-02-10 02:00
四半期報告書-第83期第3四半期(令和2年10月1日-令和2年12月31日)
Japanese 146.4 KB
2020-11-11 02:00
四半期報告書-第83期第2四半期(令和2年7月1日-令和2年9月30日)
Japanese 184.1 KB
2020-08-07 03:00
四半期報告書-第83期第1四半期(令和2年4月1日-令和2年6月30日)
Japanese 138.0 KB

Automate Your Workflow. Get a real-time feed of all EIKEN CHEMICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for EIKEN CHEMICAL CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for EIKEN CHEMICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.